Alto Neuroscience, Inc.
ANRO
$2.28
$0.010.44%
NYSE
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 6.37% | 12.97% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -10.00% | 2.97% | |||
| Operating Income | 10.00% | -2.97% | |||
| Income Before Tax | 9.43% | -4.70% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 9.43% | -4.70% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 9.43% | -4.70% | |||
| EBIT | 10.00% | -2.97% | |||
| EBITDA | 10.32% | -2.94% | |||
| EPS Basic | 8.79% | -4.52% | |||
| Normalized Basic EPS | 8.82% | -4.51% | |||
| EPS Diluted | 8.79% | -4.52% | |||
| Normalized Diluted EPS | 8.82% | -4.51% | |||
| Average Basic Shares Outstanding | -0.69% | 0.17% | |||
| Average Diluted Shares Outstanding | -0.69% | 0.17% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||